Successful treatment of a primary cardiac leiomyosarcoma with ifosfamide and etoposide.
Primary cardiac leiomyosarcoma is a rare malignant tumor in childhood. Patients with unresectable or partially resected cardiac leiomyosarcoma typically have a poor prognosis. The role of chemotherapy in the treatment of these patients has not been well defined. A 6-week-old infant with an incompletely resected cardiac leiomyosarcoma was treated postoperatively with ifosfamide and etoposide. The patient is disease-free and without apparent late effects 5 years following the completion of therapy. The combination of ifosfamide and etoposide warrants further evaluation in patients with leiomyosarcoma.